Cystic fibrosis

Radiation lung injury

Share this

Radiation lung injury

The lung is an exquisitely radiosensitive organ that can be damaged by external beam radiation therapy. The degree of pulmonary injury is determined by the volume of lung irradiated, the dose and rate of exposure, and potentiating factors (eg, concurrent chemotherapy, previous radiation therapy in the same area, and simultaneous withdrawal of corticosteroid therapy). Symptomatic radiation lung injury occurs in about 10% of patients treated for carcinoma of the breast, 5–15% of patients treated for carcinoma of the lung, and 5–35% of patients treated for lymphoma. Two phases of the pulmonary response to radiation are apparent: an acute phase (radiation pneumonitis) and a chronic phase (radiation fibrosis).

Radiation Pneumonitis

Acute radiation pneumonitis usually occurs 2–3 months (range 1–6 months) after completion of radiotherapy and is characterized by insidious onset of dyspnea, intractable dry cough, chest fullness or pain, weakness, and fever. Late radiation pneumonitis may develop 6–12 months after completion of radiation. The pathogenesis of acute radiation pneumonitis is unknown, but there is speculation that hypersensitivity mechanisms are involved.

The dominant histopathologic findings are a lymphocytic interstitial pneumonitis progressing to an exudative alveolitis. Inspiratory crackles may be heard in the involved area. In severe disease, respiratory distress and cyanosis occur that are characteristic of ARDS. An increased white blood cell count and elevated sedimentation rate are common. Pulmonary function studies reveal reduced lung volumes, reduced lung compliance, hypoxemia, reduced diffusing capacity, and reduced maximum voluntary ventilation.


Chest radiography, which correlates poorly with the presence of symptoms, usually demonstrates alveolar or nodular opacities limited to the irradiated area. Air bronchograms are often observed. Sharp borders of an opacity may help distinguish radiation pneumonitis from other conditions, such as infectious pneumonia, lymphangitic spread of carcinoma, and recurrent tumor; however, the opacity may extend beyond the radiation field.

No specific therapy is proved to be effective in radiation pneumonitis, but prednisone (1 mg/kg/day orally) is commonly given immediately for about 1 week. The dose is reduced and maintained at 20–40 mg/day for several weeks, then slowly tapered. Radiation pneumonitis may improve in 2–3 weeks following onset of symptoms as the exudative phase resolves. Acute respiratory failure, if present, is treated supportively. Death from ARDS is unusual in radiation pneumonitis.

Pulmonary Radiation Fibrosis

Radiation fibrosis may occur with or without antecedent radiation pneumonitis. Cor pulmonale and chronic respiratory failure are rare. Radiographic findings include obliteration of normal lung markings, dense interstitial and pleural fibrosis, reduced lung volumes, tenting of the diaphragm, and sharp delineation of the irradiated area.

No specific therapy is proven effective, and corticosteroids have no value. Pulmonary fibrosis may develop after an intervening period (6–12 months) of well-being in patients who experience radiation pneumonitis. Pulmonary radiation fibrosis occurs in most patients who receive a full course of radiation therapy for cancer of the lung or breast. Most patients are asymptomatic, although slowly progressive dyspnea may occur.

Share this

2 thoughts on “Radiation lung injury”

  1. Hello, I read your articles very well. Your article is very helpful for everybody. Supper articles really it is very helpful. I have a website that’s I write about Herrpecy.
    Herpes is a common health condition that affects many people around the world. It is an embarrassing condition and any person who suffers often hides as the negative stigma surrounding this condition is too much. If left untreated, herpes can seriously affect the general body and organs.

    Fortunately, as herpes has become popular and is a common health problem, there are many treatment options that can help in curing herpes. However, one of the most popular treatments that has become effective and works well is Herpesyl.

    This new supplement has the ability to fight the virus that causes herpes. The product completely cures this condition with no future relapses. It is the number one diet supplement that has been shown to be more effective in helping to treat herpes quickly.

    What’s Herpesyl?

    For those new to this salutary supplement, Herpesyl is a new salutary supplement available in capsule form that provides briskly relief from the popular simplex contagion. The supplement works by eradicating and precluding HSV1 and HSV2 contagions.

    After getting that this contagion hides in the brain cells that have an extended survival rate when compared to other body cells.
    Click here for more details:

Leave a Reply

%d bloggers like this: